Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_provenance.
- NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_assertion description "[PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_provenance.
- NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_assertion evidence source_evidence_literature NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_provenance.
- NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_assertion SIO_000772 18089823 NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_provenance.
- NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_assertion wasDerivedFrom befree-2016 NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_provenance.
- NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_assertion wasGeneratedBy ECO_0000203 NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_provenance.
- befree-2016 importedOn "2016-02-19" NP646019.RAznQcOJpPK7W-9wGTIHSyOW6MNRWVnsehLZZgEO1I2IU130_provenance.